Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome

American Journal of Nephrology

Volumn 36, Issue 6, 2012, Pages 516-523

  Ohara, Shinichiro ^a   Kawasaki, Yukihiko ^a   Abe, Yusaku ^a   Watanabe, Masahiro ^a   Ono, Atsushi ^a   Suyama, Kazuhide ^a   Hashimoto, Koichi ^a   Honda, Takashi ^a   Suzuki, Junzo ^a   Hosoya, Mitsuaki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiopoietin 1; Hemolytic uremic syndrome; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; CD31 ANTIGEN; CREATININE; LIPOPOLYSACCHARIDE; VASCULOTROPIN; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLOMERULUS; HEMOLYTIC UREMIC SYNDROME; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL;

ACTINS; ACUTE KIDNEY INJURY; ANGIOPOIETIN-1; ANIMALS; ANTIGENS, CD31; CREATININE; ENDOTHELIUM; HEMOLYTIC-UREMIC SYNDROME; KIDNEY GLOMERULUS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RECOVERY OF FUNCTION; REGENERATION; SHIGA TOXIN 2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84869239340     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000345142     Document Type: Article

References (22)

1. Karmali MA, Petric M, Lim C, Fleming DC, Arthus GS, Lior H: The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherich-ia coli. J Infect Dis 1985; 151: 775-782. (Pubitemid 15094592)
2. Keir L, Coward RJ: Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Ne-phrol 2011; 26: 523-533.
3. Karpman D, Sartz L, Johnson S: Pathophysi-ology of typical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 575-585.
4. Scheiring J, Andreoli SP, Zimmerhackl LB: Treatment and outcome of Shiga-toxin-asso-ciated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008; 23: 1749-1760.
5. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 1997; 99: 2351-2357. (Pubitemid 27227711)
6. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gether HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111:707-716. (Pubitemid 36278589)
7. Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J: VEGF(165) mediates glomerular endothelial repair. J Clin Invest 1999; 104: 913-923. (Pubitemid 29536341)
8. Haas CS, Câmpean V, Kuhlmann A, Dimmler A, Reulbach U, Forster C, Aigner T, Acker T, Plate K, A mann K: Analysis of glomer u-lar VEGF mRNA and protein expression in murine mesangioproliferative glomerulone-phritis. Virchows Arch 2007; 450: 81-92. (Pubitemid 46360749)
9. Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD: Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation. Cold Spring Harb Symp Quant Biol 2002; 67: 267-273. (Pubitemid 36775520)
10. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yan-copoulos GD: Increased vascularization in mice overexpressing angiopoietin-1. Science 1997; 282:468-471.
11. Suri C, Jones PF, Patan S, Bartunkova S, Mai-sonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic an-giogenesis. Cell 1996; 87:1171-1180. (Pubitemid 27010101)
12. Long DA, Price KL, Ioffe E, Gannon CM, Gnudi L, White KE, Yancopoulos GD, Rudge JS, Woolf AS: Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int 2008; 74: 300-309. (Pubitemid 352001243)
13. Sugatani J, Igarashi T, Munakata M, Komi-yama Y, Takahashi H, Komiyama N, Maeda T, Ta keda T, Miwa M: Ac tivation of coagu la-tion in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2. Thromb Res 2000; 100:61-72.
14. Ikeda M, Ito S, Honda M: Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 2004; 19: 485-489. (Pubitemid 38594284)
15. Kar pma n D, Connel H, Svensson M, Scheut z F, Alm P, Svanborg C: The role of lipopoly-saccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 1997; 175:611-620. (Pubitemid 27086165)
16. Taylor CM, Williams JM, Lote CJ, Howie AJ, Thewles A, Wood JA, Milford DV, Raafat F, Chant I, Rose PE: A laboratory model of toxin-induced hemolytic uremic syndrome. Kidney Int 1999; 55:1367-1374. (Pubitemid 29157135)
17. Keepers TR, Psotka MA, Gross LK, Obrig TG: A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 2006; 17: 3404-3414. (Pubitemid 44865283)
18. Kawasaki Y, Tanji M, Takano K, Fukuda Y, Isome M, Nozawa R, Suzuki H, Hosoya M: The leukotriene B4 receptor antagonist ONO-4057 inhibits mesangioproliferative changes in anti-Thy-1 nephritis. Nephrol Dial Transplant 2005; 20:2697-2703. (Pubitemid 41672268)
19. Kawasaki Y, Hosoya M, Isome M, Nozawa R, Suzuki H: Renal effects of Coxsackie B4 virus in hyper-IgA mice. J Am Soc Nephrol 2006; 17:2760-2769. (Pubitemid 44484666)
20. Zhang L, Nakazawa K, Shigematsu H: Participation of endothelial cells and transformed mesangial cells in remodeling of glo-merular capillary loops in Thy-1 nephritis. Pathol Int 2001; 51: 227-239. (Pubitemid 32472693)
21. Thurston G: Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 2003; 314: 61-68. (Pubitemid 37409913)
22. Takazawa Y, Maeshima Y, Kitayama H, Yamamoto Y, Kawachi H, Shimizu F, Matsui H, Sugiyama H, Yamasaki Y, Makino H: Infusion of angiotensin II reduces loss of glo-merular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors. Kidney Int 2005; 68:704-722. (Pubitemid 43323126)